Byondis Is A Clinical Stage Biopharmaceutical Research And Development Company Based In Nijmegenthe Netherlandsfounded In 2007 As Synthon Biopharmaceuticalsit Became An Independent Entity In 2019 And Was Rebranded As Byondis In 2020The Company Is Dedicated To Developing Innovative Treatments With High Efficacy And Low Systemic Toxicity For Patients With Unmet Medical Needs Byondis Specializes In The Researchdevelopmentand Production Of Antibody Drug Conjugatesadcsand Monoclonal Antibodiesmabs Its Pipeline Showcases Expertise In Lead Identificationpreclinical And Clinical Developmentprocess Developmentand Manufacturingbyondis Aims To Create Precision Medicines Targeting Challenging Cancers And Autoimmune Diseases
